
Chief Executive Officer

Julia is a Public Health Physician and General Practitioner with sub-specialty training in tropical medicine, public health and vaccinology. Julia has undergone medical, clinical and research training in Australia and at The University of Oxford, United Kingdom. An international leader in translational medicine through pioneering of clinical trial systems entailing experimental human infection, Julia developed Australia's first influenza human infection model. As part of her PhD at The University of Oxford, she developed the world’s first human aerosol challenge model against tuberculosis, using inhaled aerosol Bacillus Calmette–Guérin (BCG) as a surrogate.
A skills-based board combines comprehensive experience in academic research, financial strategy, commercial development and biotechnology & pharmaceutical industries. Along with the specialised leadership team, this expertise drives Doherty Clinical Trials Ltd unique capabilities.